Corvus Pharmaceuticals, Inc.
CRVS •
Buy Open
Signal type
Buy
Status
Open
Open Price
$16.09
Stop Loss
$15.24
Performance
-5.22%
Days Open
1
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 14, 2026
Open Price $16.09
Stop Loss $15.24
Timespan Day
Company Profile
Name Corvus Pharmaceuticals, Inc.
Ticker CRVS
Market Cap $297.66M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $15.25
List Date Mar 23, 2016
Description
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
Website Open Company Website